Member Info for Laura2022

And further treatments

Prostate cancer is the second most prevalent cancer in men and the fifth leading cause of male cancer death globally.1 Only one third of patients with metastatic prostate cancer survive five years after diagnosis.2 Newly diagnosed mHSPC is an aggressive form of the disease associated with poor outcomes and survival.3,4 Approximately 200,000 patients are diagnosed with mHSPC each year, and one in four have PTEN-deficient tumours.5 Patients with a tumour biomarker of PTEN deficiency have a particularly poor prognosis.6

Hellodave

Another U turner

Stick to CBG

I'm expecting we'll get several news items shortly

Interesting read

Putin’s violently confrontational, lawless and dangerous behaviour – not only towards Ukraine but to the west and the international order in general – is unprecedented in modern times. How very ironic, how very chastening, therefore, is the thought that only another rogue – Trump – may have a chance of bringing him to heel.

Biden can do nothing now to halt the war. He had his chance in 2021-2022 and blew it. His missiles, landmines and extra cash have probably come too late. And in two months’ time, he will be gone.

On the other hand, Trump’s warped idea of peace – surrendering one quarter of Ukraine’s territory and barring it from Nato and the EU – may look increasingly attractive to European leaders with little idea how to curb both overt and covert Russian aggression or how to win an unwinnable war on their own.

Putin calculates that Europe, ­prospectively abandoned by the US, fears a no-longer-hybrid, only too real, all-out war with Russia more than it does the consequences of betraying Ukraine.

Cynical brute that he is, he will keep on clandestinely pushing, probing, provoking and punishing until someone or something breaks – or Trump bails him out.

FTSE finished + 1.39% DOW + 0.97%

5 candles

"Mini meltdown "

The FTSE and DOW were both up

That's half a premiership football stadium

Hardly representative!!

Geez

Usual caveats as from WG themselves

*The $230bn addressable opportunity statistic is sourced from Wood Group's Capital Markets Day, held on 29th November 2022.

It is our understanding that Apollo's decision to withdraw was not related to any information revealed by the due diligence phase of the approach. This does not come as a surprise to us, given Apollo will have already analysed the extensive financial information published recently by Wood Group, including its financial statements for the year to December 2022 which were published alongside the full year results presentation on the 28th of March 2023.

In our December 2022 letter to Wood, we highlighted that, given the material undervaluation of the shares, the company was vulnerable to an opportunistic takeover approach; subsequent events have clearly vindicated this view. Given that the business prospects have continued to improve, but the share price is the same, we can only conclude that this vulnerability is even greater today.

Further information on Dr Sargent:

Prior to joining Physiomics in September 2023, Dr Sargent held a senior management role at global consultancy business Syneos Health Inc (NASDAQ: SYNH), leading large teams of professionals and servicing a variety of clients in the biopharmaceuticals space. Among his other previous roles, Dr Sargent has also been Head of Business Development for the UK's National Institute for Health and Care Research (NIHR), leading a team supporting global life science businesses access to funding and research infrastructure in the UK.

Given that PS has many connections maybe PYC can follow on from this other UK bio tech ladt week which announced (GDR)

 The goal of NIHR and the Government's Office for Life Sciences via this programme is to drive adoption and implementation of innovative technologies such as ours into the UK's NHS, to drive improved patient outcomes and economic benefits."

Really awful

How do these people sleep ..

FarEnd

Please give me a bit more credit..."recruited "!!

How patronising and misogynistic

This appears the danger where the founders or major holders own 40-50% on small companies

They can ride rough shod over ordinary SHs

ShareholderNumber of SharesPercentage of issued share capitalBurnbrae Limited248,204,44263.10

Number of AIM securities in issue

The number of AIM securities in issue currently is 393,338,310 and no shares are held as treasury shares.

Percentage of AIM securities not in public hands.

So far as the company is aware, 63.10% of the company’s ordinary shares of 1p each are not in public hands.

Amd I assume no one cam stop this with 60% holding ?

It didn't go unnoticed and thankyou

STP

It's a toxic masculine right wing den on here last 12mths

Elite

There CANNOT be director buys until after review

Communism

:) :)

Wow..vivd sense of imagination

Gate

Almost all on that list were already happening under the Tories